5 results
10-K
2023 FY
SLRN
Acelyrin Inc
28 Mar 24
Annual report
4:21pm
to the FDA as part of a BLA, along with proposed labeling, chemistry and manufacturing information to ensure product quality and other relevant data
424B4
SLRN
Acelyrin Inc
5 May 23
Prospectus supplement with pricing info
4:22pm
to the FDA as part of a BLA, along with proposed labeling, chemistry and manufacturing information to ensure product quality and other relevant data
S-1/A
SLRN
Acelyrin Inc
1 May 23
IPO registration (amended)
6:10am
and manufacturing information to ensure product quality and other relevant data. The BLA is a request for approval to market the biologic for one or more specified
S-1
SLRN
Acelyrin Inc
13 Apr 23
IPO registration
5:10pm
to ensure product quality and other relevant data. The BLA is a request for approval to market the biologic for one or more specified indications
- Prev
- 1
- Next